Background illustration for clinical trials search

Paid Clinical Trials Georgia

Discover 1,918 paid clinical trials in Georgia. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,918

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

for

Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor,

Location: St. John's, Halifax, Bangor ME, Scarborough ME,

Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 30

Code: NCT04322318

Phase 2, Recruiting

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

for

Classic Follicular Lymphoma,

Location: Providence RI, Lebanon NH, Long Branch NJ,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06337318

Phase 3, Recruiting

Clinical Study of the inQB8 TTVR System (The MonarQ Study)

for

Tricuspid Valve Regurgitation

Location: Manhasset NY, Philadelphia PA, Toronto, Atlanta GA,

Sponsor: inQB8 Medical Technologies, LLC

Sex: All

Age: 18+

Code: NCT06611579

Recruiting

Steps Towards Osteoarthritis Prevention

for

Anterior Cruciate Ligament Injuries

Location: Athens GA

Sponsor: University of Georgia

Sex: All

Age: 16 - 40

Code: NCT06193343

Recruiting

Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation

for

Infusion Reactions

Location: Boston MA, Lake Success NY, New Hyde Park NY,

Sponsor: New York Blood Center

Sex: All

Age: 0+

Code: NCT01656603

Phase 2, Recruiting

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

for

Anaplastic Large Cell Lymphoma, ALK-Negative,

Location: Millville DE, Lewes DE, Rehoboth Beach DE,

Sponsor: Eastern Cooperative Oncology Group

Sex: All

Age: 18 - 70+

Code: NCT06724237

Phase 3, Recruiting

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

for

Acute Myeloid Leukemia,

Location: Halifax, Brunswick ME, Portland ME, Scarborough ME,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05564390

Phase 2, Recruiting

Proton Radiation Therapy for the Treatment of Patients With High Risk Prostate Cancer

for

Stage III Prostate Cancer AJCC v8,

Location: Atlanta GA

Sponsor: Emory University

Sex: Male

Age: 18+

Code: NCT04725903

Recruiting

A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

for

Childhood Medulloblastoma

Location: Halifax, Boston MA, Providence RI, Hartford CT,

Sponsor: Children's Oncology Group

Sex: All

Age: 4 - 21

Code: NCT05382338

Phase 3, Recruiting

Evaluate the SENSE Device's Ability to Monitor and Detect Intracranial Hemorrhage

for

Intracranial Hemorrhages, Traumatic Brain Injury

Location: Atlanta GA

Sponsor: Sense Diagnostics, LLC

Sex: All

Age: 22+

Code: NCT04642443

Recruiting

Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning

for

Severe Combined Immunodeficiency, X Linked, Gene Therapy

Location: Boston MA, Atlanta GA, Cincinnati OH, Los Angeles CA

Sponsor: David Williams

Sex: Male

Age: 0 - 5

Code: NCT03311503

Phase 1, Phase 2, Recruiting

A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer

for

Metastatic Castration-resistant Prostate Cancer

Location: White Plains NY, Albany NY, Norfolk VA, Rockville MD,

Sponsor: BioNTech SE

Sex: Male

Age: 18+

Code: NCT07365995

Phase 3, Recruiting

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

for

Recurrent Lung Non-Small Cell Carcinoma,

Location: Brewer ME, Rockport ME, Belfast ME, Damariscotta ME,

Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT06616584

Phase 2, Phase 3, Recruiting

Evaluation of the Safety of Loargys Arginine Test System in Loargys-treated Patients

for

ARG1 Deficiency

Location: Atlanta GA

Sponsor: Immedica Pharma US Inc

Sex: All

Age: 0 - 70+

Code: NCT07573059

Recruiting

DFT383 in Pediatric Participants With Nephropathic Cystinosis

for

Nephropathic Cystinosis

Location: Philadelphia PA, Atlanta GA, Houston TX, Phoenix AZ,

Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 2 - 5

Code: NCT06910813

Phase 1, Phase 2, Recruiting

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

for

Locally Advanced Breast Cancer, Unresectable Breast Carcinoma,

Location: New York NY, Stony Brook NY, Chicoutimi, Uniondale NY,

Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT06827236

Phase 1, Phase 2, Recruiting

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

for

Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8,

Location: Saint John, Bath ME, Portland ME, Scarborough ME,

Sponsor: NRG Oncology

Sex: Male

Age: 18+

Code: NCT05946213

Phase 3, Recruiting

Educational, Social Support, and Nutritional Interventions and Their Cumulative Effect on Pregnancy Outcomes and Quality of Life in Teen and Adult Women With Phenylketonuria

for

Pregnancy, Phenylketonuria

Location: Atlanta GA

Sponsor: Emory University

Sex: Female

Age: 11+

Code: NCT01659749

Recruiting

A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)

for

Narcolepsy Type 2

Location: Middletown NJ, Norfolk VA, Bowie MD, Miami FL,

Sponsor: Takeda

Sex: All

Age: 18 - 70

Code: NCT06952699

Phase 2, Recruiting

Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer

for

Metastatic Nasopharyngeal Carcinoma,

Location: Commack NY, Uniondale NY, Harrison NY, New York NY,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06029270

Phase 2, Recruiting

Popular cities in Georgia

Athens Sandy Springs Atlanta Newnan Augusta Savannah

Paid Clinical Trials Georgia

Filter results

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

Clinical Study of the inQB8 TTVR System (The MonarQ Study)

Steps Towards Osteoarthritis Prevention

Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation

Interested in new trials?

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Proton Radiation Therapy for the Treatment of Patients With High Risk Prostate Cancer

A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

Evaluate the SENSE Device's Ability to Monitor and Detect Intracranial Hemorrhage

Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning

A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Evaluation of the Safety of Loargys Arginine Test System in Loargys-treated Patients

DFT383 in Pediatric Participants With Nephropathic Cystinosis

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Educational, Social Support, and Nutritional Interventions and Their Cumulative Effect on Pregnancy Outcomes and Quality of Life in Teen and Adult Women With Phenylketonuria

A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)

Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer

Popular cities in Georgia